Analystreport

Revance Therapeutics Inc (NASDAQ: RVNC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

Revance Therapeutics, Inc.  (RVNC) 
Last revance therapeutics, inc. earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.revance.com